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Abstract Many investigations have demonstrated the
prophylactic effect of Nigella sativa on asthma disease. One
of its active constituents is a-hederin. In the present study,
the preventive effect of two different concentrations of
a-hederin on tracheal responsiveness and lung inflamma-
tion in ovalbumin-sensitized guinea pigs was examined.
Forty male adult Dunkin-Hartley guinea pigs were ran-
domly divided into the control (C), sensitized (S) and sen-
sitized pretreated groups with thymoquinone (3 mg/kg i.p.,
S ? TQ), low-dose a-hederin (0.3 mg/kg i.p., S ? LAH)
and high-dose a-hederin (3 mg/kg i.p., S ? HAH). The
responsiveness of tracheal smooth muscle (TR) to metha-
choline, histamine and ovalbumin was assessed. Moreover,
total and differential white blood cell counts in lung lavage
fluid were examined. Compared with the S group, the mean
EC50 value in the S ? LAH group increased significantly
(p \ 0.05). The mean EC50 value of histamine contraction
in the S ? LAH and S ? HAH groups was significantly
higher than in the S group (p \ 0.05). In all pretreated
groups, the TR to ovalbumin decreased in comparison to the
S group (p \ 0.001). Both the S ? HAH and S ? LAH
groups showed significantly decreased TR compared to the
S ? TQ group (p \ 0.01–p \ 0.01). Total WBC and
eosinophil counts in all pretreated groups decreased sig-
nificantly in comparison with the S group (0.001–0.01).
There was a significant increase in neutrophil, lymphocyte
and monocyte counts in the pretreated groups compared to
the S group (p \ 0.001–p \ 0.05). The basophil count in
the S ? TQ and S ? HAH groups was significantly lower
than in the S group (p \ 0.01–p \ 0.05). This study sug-
gested that a-hederin has anti-inflammatory and bron-
chodilatory effects like thymoquinone.
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Introduction
Allergic asthma is a severe inflammatory disorder of the
lungs with bronchial hyperreactivity, recruitment of eosi-
nophils, mast cells and lymphocytes, and hyperplasia of the
smooth muscle and goblet cells, often related to increased
serum IgE concentrations [1]. The inflammatory response
of asthma is considered to be increased by T helper 2 type
cells through multiple cytokines [2].
Nigella sativa (black seed) is an important medicinal
herb. In many countries, for example, the Arabian, Asian
and African countries, black seed oil is used as a natural
cure for many diseases, including different allergies [3].
However, the exact mechanism of action has not been
identified yet.
Much research carried out in vitro and studies on
laboratory animals and humans in vivo have been carried
out to examine its different pharmacological features [4].
The potential prophylactic effect of this plant has been
demonstrated in asthmatic patients. Moreover, the pro-
phylactic and bronchodilatory effects of the boiled extract
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from N. sativa on asthmatic patients have been shown [5,
6]. In addition, the beneficial role of N. sativa in reducing
the wheezing associated with lower respiratory tract illness
in children [7] and adult asthmatic attacks has been re-
ported [8]. The antitussive effect of N. sativa in guinea pigs
has also been documented [9, 10]. Moreover, the preven-
tive effect of the hydroethanolic extract of N. sativa in
ovalbumin-sensitized guinea pigs and rats, an animal
model of asthma, was also shown [11–13]. Recently, the
preventive effect of the hydroethanolic extract of this plant
was proven in the tracheal responsiveness of cigarette
smoke-exposed guinea pigs [14].
Many active components have been separated from N.
sativa, including thymoquinone, thymohydroquinone,
dithymoquinone, thymol, carvacrol, nigellimine-N-oxide,
nigellicine, nigellidine and a-hederin. a-Hederin was also
separated from Hedera helix (Hedera helix L.), a famous
plant known as ivy or English ivy and a member of the
Araliaceae family. a-Hederin has been shown to have an
anti-inflammatory effect [15].
In the present study, the preventive effect of two dif-
ferent concentrations of a-hederin on tracheal responsive-
ness and lung inflammation in ovalbumin-sensitized guinea
pigs was examined.
Materials and methods
Forty male adult Dunkin-Hartley guinea pigs (400–700 g)
were selected for the study. They were accommodated in
individual cages kept at 22 ± 2 C on a 12-h light/dark
cycle. After 10 days, the animals were randomly divided
into five groups: the control group (C); sensitized group
(S); sensitized groups pretreated with thymoquinone (Sig-
ma Chemical Ltd., UK), 3 mg/kg [13] (S ? TQ); low-dose
a-hederin (Extrasynthese Co., France), 0.3 mg/kg (S ?
LAH); and high-dose a-hederin, 3 mg/kg (S ? HAH).
These were injected intraperitoneally on the 10th day of the
induction protocol.
This study was approved by the ethics committee of
Tabriz University of Medical Sciences.
Animal sensitization
Sensitization of the animals to ovalbumin was done using a
previously described method [16]. Briefly, guinea pigs
were sensitized to ovalbumin (Sigma Chemical Ltd., UK)
by injecting 100 mg i.p. and 100 mg s.c. on the 1st day and
a further 10 mg i.p. on the 8th day. From the 14th day,
sensitized animals were exposed to an aerosol of 4 %
ovalbumin for 18 ± 1 days for 4 min daily. The aerosol
was administered in a 30 9 20 9 20-cm closed chamber
using a nebulizer (Omron Healthcare, Inc., USA). Control
animals were treated similarly, but saline was used instead
of the ovalbumin solution.
Tissue preparations
Tracheas were detached from guinea pigs killed by a hit on
their neck. Each trachea was separated into ten rings (each
containing 2–3 cartilaginous rings). Afterwards, all the
rings were cut open opposite the tracheal muscle and su-
tured together to form a tracheal chain [16]. Tissue was
then suspended in a 20-ml organ bath (Schuler Organ Bath
type 809, March-Hugstetten, Germany) containing Krebs-
Henseleit solution of the following composition (mM):
NaCl 120, NaHCO3 25, MgSO4 0.5, KH2PO4 1.2, KCl
4.72, CaCl2 2.5 and dextrose 11. The Krebs solution was
kept at 37 C, pH 7.4, and gassed with 95 % O2 and 5 %
CO2. Tissue was suspended under an isotonic tension of
1 g and allowed to balance for at least 1 h while being
washed with Krebs solution every 15 min [17].
An isometric transducer (AD Instruments, Spain) with a
sensitivity range of 0–25 g was used to measure the re-
sponses. These responses were kept on a four-channel
PowerLab recorder (ML-750; March-Hugstetten, Ger-
many) after amplification with an ML/118 quadri-bridge
amplifier (March-Hugstetten, Germany).
Assessment of the tracheal response to methacholine
The concentration-response curve of the tracheal chain was
recorded in each experiment. Successive concentrations of
methacholine hydrochloride (Sigma Chemical Ltd., UK)
including 10-7–10-2 M dissolved in saline were added
every 3 min. The contraction caused by each concentration
and the effect attaining a plateau in all experiments were
documented at the end of 3 min. Then the percentage of the
tracheal smooth muscle contraction due to each concen-
tration of methacholine in proportion to the maximal
contraction obtained by its final concentration was plotted
against the log concentration of methacholine. A concen-
tration-response curve of methacholine was obtained for
the tracheal chain of each animal studied. The useful
concentration of methacholine causing 50 % maximum
response (EC50) was calculated from the methacholine
response curve in each experiment by using 50 % of the
maximum response in the Y axis and measuring the dose of
methacholine causing this response in the X axis. The
contractility response to 10 lM methacholine as the in-
tensity of the contraction was also measured [17].
Assessment of the tracheal response to histamine
Like tracheal responsiveness to methacholine, successive
concentrations of histamine (Sigma Chemical Ltd., UK)
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including 10-7–10-2 M dissolved in saline were added
every 3 min, and the contraction caused by each concen-
tration was documented at the end of these intervals [18].
Then the percentage of the tracheal smooth muscle con-
traction due to each concentration of histamine in propor-
tion to the maximal contraction obtained by its final
concentration was plotted against the log concentration of
histamine. The useful concentration of histamine causing
50 % maximum response (EC50) was calculated.
Measurement of the tracheal response to ovalbumin
The tracheal response of all animals to a 0.1 % solution of
ovalbumin was evaluated in each selected animal as fol-
lows: 0.5 ml of 4 % ovalbumin solution (dissolved in sal-
ine) was added to the 20-ml organ bath, and the contraction
of tracheal chain was recorded after 10 min, shown as a
proportion (in percentage) of the contraction obtained with
10 lM methacholine [17]. Measurements of the tracheal
response to methacholine and OA were done in random
order.
Lung lavage and white blood cell count
Compatible with preparing the tracheal chain, a cannula
was placed into the remaining trachea, and the lungs were
washed with 5 ml of saline four times (total 20 ml). One
milliliter of lung lavage fluid (LLF) was stained with Turk
solution and counted in duplicate in a hemocytometer (in
a Burker chamber). The Turk solution consisted of 1 ml
glacial acetic acid, 1 ml gentian violet solution 1 % and
100 ml pure water. The remaining LLF was centrifuged at
2,5009g at 4 C for 10 min. Then the supernatant was
removed, and a smear was prepared from the cells and
stained with Wright-Giemsa. Differential cell examina-
tion was done under a light microscope by counting 100
cells twice, and the percentage of each cell type was
measured according to staining and morphological crite-
ria [17].
Statistical analysis
All results were considered as mean ± SEM. The data of
four sensitized groups were compared with controls using
one-way analysis of variance (ANOVA) with the Tukey-
Kramer post-test. Furthermore, the data of the three treated
groups were compared with sensitized guinea pigs using
one-way analysis of variance (ANOVA) with Tukey-Kra-
mer or LSD post tests. The data of the a-hederin-treated
groups were compared with the S ? TQ group using the
unpaired t test. In addition, the data of the a-hederin-treated
groups were compared using the unpaired t test.
Results
Tracheal response to methacholine
The responsiveness of tracheal chains to different con-
centrations of methacholine is shown as concentration-re-
sponse curves in Fig. 1. Concentration-response curves in
all groups (except the S ? LAH group) showed leftward
shifts compared to the control group. In comparison to the
sensitized group, all groups shifted to the right. The highest
tracheal response was observed in the S group and the least
in the S ? LAH group (Fig. 1).
The mean EC50 value in the sensitized and S ? TQ
groups was significantly decreased compared with the
control group (p \ 0.01 for both). Compared with the S
group, the mean EC50 value increased significantly
(p \ 0.05) only in the S ? LAH group. The mean EC50
value in the S ? LAH group was significantly higher than
in the S ? TQ group, but there were no significant dif-
ferences among the a-hederin-treated groups (Table 1).
The mean value of contractility in all groups (except
S ? TQ) increased significantly in comparison with the
control group (p \ 0.001 for the S group, p \ 0.05 for the
S ? LAH and S ? HAH groups). All pretreated groups
showed significantly decreased contractility compared with
the S group (p \ 0.05 for the S ? TQ group, p \ 0.001 for
the S ? LAH group, p \ 0.01 for the S ? HAH group).
There were no significant differences among the pretreated
groups (Table 1).
Fig. 1 Cumulative log concentration-response curves of metha-
choline-induced contraction of isolated trachea in control (C),
sensitized (S), sensitized pretreated with thymoquinone (S ? TQ),
sensitized pretreated with low-dose a-hederin (S ? LAH) and with
high-dose a-hederin (S ? HAH) guinea pigs in the organ bath (for
each group, n = 7)
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Tracheal response to histamine
Concentration-response curves in all groups were shifted to
the left compared to the control group, and all cases were
shifted to the right with respect to the sensitized group. The
S ? TQ group was the closest to the control group but did
not reach the control level. The curve of the S ? LAH
group was very close to that of the S ? TQ group. The
least tracheal responsiveness was seen in the C group
(Fig. 2).
The mean EC50 value in all groups decreased sig-
nificantly in comparison to the control group (p \ 0.001
for the S group, p \ 0.05 for all pretreated groups). The
mean EC50 value in all pretreated groups was significantly
higher than in the S group (p \ 0.05 for both). There was
no significant difference among the pretreated groups
(Table 1).
Tracheal response to ovalbumin
Tracheal responsiveness to ovalbumin in all groups (except
the S ? HAH group) was significantly higher than in the
controls (p \ 0.001 for the S and S ? TQ groups, p \ 0.01
for the S ? LAH group). In all pretreated groups, the tra-
cheal response to ovalbumin decreased in comparison to
the S group (p \ 0.001 for all pretreated groups). Both the
S ? HAH and S ? LAH groups showed significantly de-
creased tracheal response compared to the S ? TQ group
(p \ 0.05 for the S ? LAH group, p \ 0.01 for the
S ? HAH group). Moreover, there was a significant dif-
ference between the S ? LAH and S ? HAH groups
(p \ 0.05, Table 1).
Table 1 Values of tracheal response to methacholine (EC50-Met)
and histamine (EC50-His), response to ovalbumin (OA), contractility
and total white blood cells (WBCs) of LLF in control (C), sensitized
(S), S treated with thymoquinone (S ? TQ), S treated with low-dose
(S ? LAH) and high-dose a-hederin (S ? HAH) guinea pigs (for
each group, n = 6)
C S S ? TQ S ? LAH S ? HAH
EC50-Met (lM) 3.95 ± 0.85 0.56 ± 0.22 0.77 ± 0.04 2.87 ± 0.87 2.22 ± 0.72
?? ?? ns NS * NS ns
# # ns
Contractility 0.60 ± 0.05 1.68 ± 0.08 1.03 ± 0.24 0.93 ± 0.12 0.98 ± 0.15
??? NS * ? *** ? *
ns ns ns
EC50-His (lM) 9.92 ± 1.14 1.54 ± 0.70 5.23 ± 1.67 4.94 ± 1.09 5.73 ± 1.44
??? ? ns ? * ? *
ns ns ns
OA 1.9 ± 1.15 72.88 ± 9.28 15.01 ± 2.37 7.78 ± 1.01 3.5 ± 1.18
??? ??? *** ?? *** NS ***
# ## !
Total WBC count 333.17 ± 31.11 878.33 ± 96.11 479.17 ± 50.62 368.33 ± 53.00 407.33 ± 62.47
??? ? ** NS *** NS **
ns ns ns
Values are presented as mean ± SEM. The WBC data are their counts in 1 ml of LLF. Statistical differences between the data of control vs.
other groups: NS nonsignificant difference; ?, p \ 0.05; ??, p \ 0.01; ???, p \ 0.001. Statistical differences between the data of sensitized
vs. pretreated groups: ns nonsignificant difference; *, p \ 0.05; **, p \ 0.01; ***, p \ 0.001. Statistical differences between the S ? TQ group
vs. the S ? LAH and S ? HAH groups: ns nonsignificant difference; #, p \ 0.05; ##, p \ 0.01. Statistical differences between the S ? LAH
and S ? HAH groups: ns nonsignificant difference; !, p \ 0.05
Fig. 2 Cumulative log concentration-response curves of histamine-
induced contraction of isolated trachea in the control (C), sensitized
(S), sensitized pretreated with thymoquinone (S ? TQ), sensitized
pretreated with low-dose a-hederin (S ? LAH) and high-dose a-
hederin (S ? HAH) guinea pigs in the organ bath (for each group,
n = 7)
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Total WBC count in lung lavage fluid
The amount of WBCs in the S and S ? TQ groups was
significantly higher than in the control group (p \ 0.001
for the S group, p \ 0.05 for the S ? TQ group). The
WBC count in all pretreated groups decreased significantly
in comparison with the sensitized group (p \ 0.01 for the
S ? TQ group, p \ 0.001 for the S ? LAH group,
p \ 0.01 for the S ? HAH group). There was no sig-
nificant difference among the pretreated groups (Table 1).
Differential count of WBCs in lung lavage fluid
There was a significant increase in the eosinophil count of
all groups (except the S ? HAH group) compared with the
control group (p \ 0.001 for the S group, p \ 0.01 for the
S ? TQ group, p \ 0.05 for the S ? LAH group). The
mean value of the eosinophil count in all pretreated groups
decreased significantly in comparison to the S group
(p \ 0.001 for all pretreated groups). There was a sig-
nificant difference between the a-hederin-treated groups
compared with the S ? TQ group (p \ 0.05 for the
S ? LAH group, p \ 0.001 for the S ? HAH group). The
eosinophil count of the S ? HAH group was significantly
lower than that of the S ? LAH group (p \ 0.01, Fig. 3a).
Compared to controls, the neutrophil count only de-
creased significantly in the S group (p \ 0.01). There was a
significant increase in all pretreated groups compared to the
S group (p \ 0.001 for the S ? TQ group; p \ 0.01 for the
S ? LAH group; p \ 0.05 for the S ? HAH group). There
was no significant difference between the pretreated groups
(Fig. 3b).
The lymphocyte count declined significantly in all
groups compared to the control group (p \ 0.001 for the S
and S ? TQ groups, p \ 0.01 for the S ? LAH group,
p \ 0.05 for the S ? HAH group). There was a sig-
nificantly increased lymphocyte count in the pretreated
groups compared with the S group (p \ 0.01 for the
S ? TQ group, p \ 0.001 for the S ? LAH and S ? HAH
groups). There was a significant difference between the a-
hederin-treated groups compared to the S ? TQ group
(p \ 0.05 for the S ? LAH group, p \ 0.01 for the
S ? HAH group). There was a significant difference be-
tween the S ? LAH and S ? HAH groups, too (p \ 0.05,
Fig. 3c).
Compared to the control group, there was a significant
decrease in the monocyte count in the S group (p \ 0.05),
but it showed significant increments in the S ? LAH and
S ? HAH groups (p \ 0.01 for the S ? LAH group,
p \ 0.05 for the S ? HAH group). There was no sig-
nificant difference between the S ? TQ and control
groups. The number of monocytes was significantly
elevated in all pretreated groups compared to the S group
(p \ 0.05 for the S ? TQ group, p \ 0.001 for the
S ? LAH group, p \ 0.01 for the S ? HAH group). The
S ? HAH and S ? LAH groups showed a significant in-
crease compared to the S ? TQ group (p \ 0.05 for the
S ? LAH group, p \ 0.01 for the S ? HAH group). There
was no significant difference between the S ? LAH and
S ? HAH groups (Fig. 3d).
In comparison to the basophil count of the control
group, there was a significant increase in the S group
(p \ 0.05) and significant decrease in the S ? TQ group
(p \ 0.05). There was no significant difference in the ba-
sophil count between the a-hederin-treated groups and
controls. The basophil count in the S ? TQ and S ? HAH
groups was significantly lower than that in the S group
(p \ 0.01 for S ? TQ group, p \ 0.05 for the S ? HAH
group). The S ? LAH group showed a significantly
elevated basophil count compared to the S ? TQ group
(p \ 0.05), but there was no significant difference between
the S ? HAH and S ? TQ group. Moreover, there was no
significant difference between the S ? HAH and
S ? LAH groups (Fig. 3e).
Discussion
In the present study, the effects of a-hederin on tracheal
responsiveness to methacholine, histamine and OA as well
as the total and differential cell count in lung lavage fluid
of ovalbumin-sensitized guinea pigs were examined.
The results showed significantly increased tracheal re-
sponsiveness to methacholine, histamine and OA as well as
an increased contractility response, increment of the LLF
total WBC count, eosinophil and basophil number, but
decreased neutrophil, lymphocyte and monocyte counts in
the sensitized group compared to control animals. These
results were similar to the results of previous studies [12,
16]. Moreover, tracheal responsiveness to methacholin in
all groups was higher than in histamine-induced contrac-
tions. This might be due to the direct effect on smooth
muscle or indirect effect of histamine via nerves or
mediators.
The drugs used for preventing asthma should be able to
reduce airway inflammation, which is the main character-
istic of this disease. In the present study, most of above
changes were improved by peritoneal injection of thymo-
quinone. The anti-inflammatory and antitussive effect of
thymoquinone on different animal models of asthma has
been shown in previous studies [10, 13, 16, 19]. Previously,
the main effect of thymoquinone was shown to be on LLF
total WBC and eosinophil counts [20], which our current
study confirmed.
In this investigation, the injection of two different doses
of a-hederin could reduce the tracheal responsiveness to
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methacholine, histamine and ovalbumin as well as the
contractility and EC50 increment compared to the sensi-
tized group. Even low-dose a-hederin can decrease the
tracheal responsiveness to methacholine to lower levels
compared to the control level.
a-Hederin is a triterpenoid saponin. Triterpenoids have a
variety of biological effects, e.g., anti-inflammatory [21].
Preclinical studies analyzing living cells and the regulation
of b2-adrenoceptors recently identified a-hederin as the
main active constituent among saponins isolated from ivy
[22]. Gepdiremen described the acute anti-inflammatory
activity of a-hederin in carrageenan-induced rat paw ede-
ma [15]. In clinical studies, treatment of acute and chronic
bronchial inflammatory diseases with a dry extract of ivy
leaves improved symptoms such as coughing and viscous
mucus secretion as well as lung function parameters such
as increased airway resistance in patients with obstructive
airway diseases [23].
Fig. 3 The percentages of
eosinophils (a), neutrophils (b),
lymphocytes (c), monocytes
(d) and basophils (e) in lung
lavage fluid in the control,
sensitized (S), sensitized
pretreated with thymoquinone
(S ? TQ), sensitized pretreated
with low-dose a-hederin
(S ? LAH) and high-dose a-
hederin (S ? HAH) guinea pigs
(for each group, n = 15).
Statistical differences between
the control and different groups:
ns, nonsignificant difference; ?,
p \ 0.05; ??, p \ 0.01; ???,
p \ 0.001. Statistical
differences between pretreated
groups vs. the sensitized group:
NS, nonsignificant difference; *,
p \ 0.05; **, p \ 0.01; ***,
p \ 0.001
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The exact mechanisms of action of a-hederin are not
clear yet, but a previous study reported an elevated b2-
adrenergic responsiveness in a-hederin pretreated human
airway smooth muscle cells after stimulation with terbu-
taline and forskolin [22]. Another study suggested that a-
hederin elevated b2-adrenergic responsiveness by increas-
ing cAMP levels [23]. Elevated cAMP levels lead to an
increased phosphorylation of myosin light-chain kinase
(MLCK) by protein kinase A (PKA), which caused a re-
duced sensitivity of MLCK to calcium [24]. Moreover,
cAMP inhibited calcium ion release from intracellular
pools and decreased calcium entry into cells [25]. a-Hed-
erin also inhibited the internalization of b2-adrenergic re-
ceptors in stimulated airway smooth muscle cells [22].
Hegener and coworkers have suggested that the secre-
tolytic and bronchodilating properties found in Hedera
helix extract are due to its saponin content, particularly a-
hederin as an inhibitor of B2 receptor endocytosis, estab-
lishing an indirect B2 sympathomimetic action [26].
Also an antioxidant effect was suggested for a-hederin.
Airway inflammatory cells could produce active types of
oxygen such as superoxide and peroxide. These active types
of oxygen directly caused bronchial contraction, stimulated
histamine release from mast cells and also excreted mucus
by epithelial airway cells [27]. On the other hand, oxidative
stress played an important role in airway inflammation in
asthma disease [28], and a decrease in different components
of the antioxidant defense system (enzymatic or nonenzy-
matic) in patients with asthma was observed [29].
In this study, the prescription of a-hederin at two dif-
ferent doses decreased the total WBC count, eosinophil and
basophil numbers, and increased the number of neutrophils,
monocytes and lymphocytes in LLF compared to the sen-
sitized group. These changes indicated that the injection of
a-hederin before the induction of asthma in ovalbumin-
sensitized animals had a great impact on the total WBC
count, eosinophil and lymphocyte numbers. These results
showed that a-hederin had more impact on eosinophilic
inflammation in animals sensitized with ovalbumin.
This study showed that the peritoneal injection of both
doses of a-hederin could decrease the tracheal respon-
siveness to ovalbumin. This amount of reduction was more
than the effect of thymoquinone at the studied dose. Re-
garding the changes in the lungs and airways of the studied
animals, the results showed that the effects of a-hederin on
the eosinophil and lymphocyte counts of LLF were greater
than those of thymoquinone. In addition, the results of this
study indicated that a-hederin had dilatory and antiasth-
matic effects similar to those of thymoquinone. Further-
more, a high dose of a-hederin had a greater decreasing
effect on tracheal responsiveness to ovalbumin and the
LLF eosinophil count compared to a low dose. Even the
LLF eosinophil count in the pretreated group with high-
dose a-hederin came down to the control limit. In con-
clusion, a-hederin probably has anti-inflammatory and
dilatory effects like thymoquinone.
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